Nav Chandel weighs mitochondria evidence on Attia podcast
The 79-minute episode separates cell-biology mechanisms from claims around metformin, urolithin A, alpha-ketoglutarate and other interventions.

Nav Chandel discussed mitochondria, metformin and supplements in episode #416 of The Peter Attia Drive, a 79-minute podcast published Nov. 16.
Chandel’s Nov. 16 podcast appearance matters because mitochondria are often presented as simple energy factories, while the episode focused on signaling, inflammation and limits in longevity claims.
Peter Attia, host of The Peter Attia Drive, introduced Chandel as “one of the most thoughtful scientists I know in this space, especially when it comes to separating what we think we know about mitochondria from what the data actually support.”
Chandel is described in the episode page as a distinguished professor who studies mitochondrial biology and the role mitochondria play in aging and chronic disease. The conversation returned to a basic point often lost in wellness marketing: mitochondria do more than make ATP, or adenosine triphosphate, the molecule cells use for energy.
The episode covered how mitochondria may communicate through hydrogen peroxide, metabolites, and mitochondrial DNA and RNA. The show notes link those signals to inflammation, immune function and epigenetic regulation, which refers to changes in gene activity that do not alter the DNA sequence.
The discussion also examined the phrase “mitochondrial dysfunction,” which Chandel and Attia treated as a term that can be used too loosely in aging conversations. Chandel’s framing, quoted on the episode page, was: “If mitochondrial dysfunction is related to aging, it isn't simply about running out of ATP or running out of metabolites. It could be this miscommunication.”
Metformin was a major part of the episode. The show notes say Chandel discussed gut accumulation, complex I inhibition and indirect effects on metabolism and exercise. Complex I is part of the mitochondrial electron transport chain, a system involved in cellular energy production.
The episode also addressed whether metformin has geroprotective benefits beyond glucose control. The show notes say Chandel examined possible effects in age-related disease prevention, while also discussing why cancer-trial findings have been disappointing and why efficacy may depend on tumor-specific uptake.
Chandel also assessed several popular mitochondrial supplements and interventions, including urolithin A, alpha-ketoglutarate, citrulline, carnitine, CoQ10, NR, NMN, SS-31, methylene blue, hyperbaric oxygen, low-oxygen therapy and red light therapy.
For readers, the useful distinction is between mechanisms that help explain cell biology and claims that an intervention improves health or longevity. This podcast discussion is not a clinical guideline and does not establish that any supplement or therapy improves mitochondrial function in people.
Source: podcast episode, The Peter Attia Drive, Nov. 16, 2026.
Atlas360 reports health research and does not provide medical advice.
More stories
- Dietitians advise small swaps for plant-based eating
- TikTok dementia videos mislead in 66.4% of sample, researchers say
- Aberdeen Royal Infirmary faces police inquiry call over 19 deaths
- Bariatric surgery group loses 28.2% after GLP-1 use
- TOFA boosts mouse energy use 18% while preserving muscle
- ICO probes NHS therapy notes accessible to up to 140,000 staff
- Singapore CDA gains first WHO infection-control centre role
- Longer estrogen exposure ties to 8% lower brain-vessel disease odds
Latest news
- David Parr House to honor Victorian art-workman with blue plaque
- Iran's attacks hit 25 tankers near Strait of Hormuz
- FCC approves prison cellphone jamming despite 2.5-mile warning
- Russia strikes Ukraine as Odesa faces electricity strain
- Bahrain reports two injuries after Iranian aerial attacks
- Congress tests Black Democrats' growing policy influence
- Baltic responders fight Sparta II fire after drone strike
- Europe faces attribution gap after 16 cyber, physical incidents

